Prophylaxis versus preemptive therapy for cytomegalovirus disease in high‐risk liver transplant recipients
Marta Bodro, Núria Sabé, Laura Lladó, Carme Baliellas, Jordi Niubó, Jose Castellote, Joan Fabregat, Antoni Rafecas, Jordi Carratalà – 24 April 2012 – Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid organ transplantation, and it contributes significantly to mortality and morbidity. CMV‐seronegative recipients of grafts from CMV‐seropositive donors have the highest risk of CMV disease. The most appropriate strategy for preventing CMV disease in this population is a matter of active debate.